RALEXAR THERAPEUTICS
Ralexar Therapeutics company is developing topical and systemic therapies based on the Liver X Receptor (LXR) modulators. The initial focus for the company is on the clinical development of ALX-101, a topical LXR-based therapy, for the treatment of various cutaneous inflammatory disorders, including atopic dermatitis. Alexar changes its name to Ralexar Therapeutics. The company was founded in 2013 and is based in Malvern, Pennsylvania.
RALEXAR THERAPEUTICS
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2013-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.ralexar.com
Total Employee:
1+
Status:
Closed
Contact:
484-318-2988
Email Addresses:
[email protected]
Total Funding:
41.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Font Awesome Apache Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail GoDaddy DNS GoDaddy
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Cellerant Therapeutics
Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Horizon Pharma
Horizon Therapeutics focuses on the development of prescription drugs for mild to moderate pain relief and arthritis.
Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Science Ventures
New Science Ventures investment in Series A - Ralexar Therapeutics
Third Point Ventures
Third Point Ventures investment in Series A - Ralexar Therapeutics
Official Site Inspections
http://www.ralexar.com
- Host name: 201.59.153.160.host.secureserver.net
- IP address: 160.153.59.201
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Ralexar Therapeutics"
Ralexar Therapeutics, Inc. - Crunchbase Company Profile & Funding
Organization. Ralexar Therapeutics, Inc. Connect to CRM . Save . Summary. People. Signals & News. About. life sciences company. Private; Recent News & Activity. There is no recent news …See details»
Ralexar Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 640 Lee Road Suite 118. Wayne, Pennsylvania, 19087, United States. 484-318-2988See details»
Ralexar Therapeutics - Craft
Ralexar Therapeutics has 1 employees at their 1 location. See insights on Ralexar Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Ralexar Therapeutics - Company Profile - Tracxn
Ralexar Therapeutics - Liver X Receptor (LXR) modulators for topical dermatological therapies.. This company is not active anymore. Raised a total funding of $29.9M over 4 rounds from 3 …See details»
Ralexar Therapeutics - PitchBook
Ralexar Therapeutics General Information Description. Developer of topical and systemic therapies designed to treat various dermatological conditions. The company's therapies are …See details»
Ralexar Therapeutics Corporate Headquarters, Office Locations …
Ralexar Therapeutics is headquartered in Chesterbrook, 640 Lee Rd #118, United States, and has 1 office location.See details»
Ralexar Therapeutics - Crunchbase Company Profile & Funding
Ralexar Therapeutics company is developing topical and systemic therapies based on the Liver X Receptor (LXR) modulators. The initial focus for the company is on the clinical development of …See details»
Raised $29.9M Funding from 3 investors - Tracxn
Mar 25, 2025 Ralexar Therapeutics has raised a total funding of $29.9M over 4 rounds from 3 investors. Investors include Third Point Ventures, The Michael J. Fox Foundation and 1 other. …See details»
Ralexar Therapeutics - Contacts, Employees, Board Members, …
Ralexar Therapeutics focuses on the development of an innovative portfolio of liver X receptor agonists.See details»
Ralex Advanced Precision Inc.
Honesty, integrity & trust is the backbone of who we are and the reason our clients keep coming back!See details»
Research programme: liver X receptor agonists - Ralexar ... - Springer
If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with username/password or try to …See details»
Ralexar Therapeutics - VentureRadar
"Ralexar Therapeutics is developing novel Liver X Receptor (LXR) modulators for topical dermatological therapies and is currently advancing its lead candidate ALX-101 through …See details»
Ralexar Therapeutics CEO, Founder, Key Executive Team, Board of ...
Explore {Ralexar Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Ralexar Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 6, 2017: Venture Round - …See details»
ralex advanced precision in Palmdale, CA 93550 - 661-874...
About ralex advanced precision. ralex advanced precision is located at 38841 20th St E in Palmdale, California 93550. ralex advanced precision can be contacted via phone at 661-874 …See details»
Contact 1 - Ralex Advanced Precision Inc.
Contact US. Feel free to reach out to us for a quote, to ask a question… or, to simply say “hello!” No matter the reason, we are happy to connect with you!See details»
Ralexar Therapeutics - VentureRadar
Similar Companies: Moleculin USA Publicly Traded Moleculin Biotech, Inc. is a clinical stage pharmaceutical company focused on the development of a broad portfolio of oncology drug …See details»
Contact 1 — Ralex Advanced Precision Inc.
Ralex Advanced Precision has been trusted by leading companies in the Areospace & Mining Industries such as:See details»
Gallery - Ralex Advanced Precision Inc.
Skip to ContentSee details»
Contact 1 — Ralex Advanced Precision Inc.
Since 2012 we have successfully completed hundreds of various machine repairs, maintenance and modifications in California. As a family owned company, we treat each of our clients as if …See details»